PAASA , SPEEDHOPE IVAN E.

Group 3
Activity I. TRUE OR FALSE. Write T if the statement is true and F if false. Write your answers on the space provided
before each number.

T 1. Protamine sulfate is heparins antidote.

F 2. Heparin is the most commonly used anticoagulant.
T 3.Antilipidemic drugs inhibit platelet aggregation.
T 4.It is specifically recommended to keep anticoagulant medication in original packaging until administered.
F 5.You may give this medication either subcutaneously or intramuscularly.
T 6.A patient on warfarin should avoid foods high in Vitamin K as they may alter the effects of warfarin
T 7.Brands should never be interchanged with a patient who is on warfarin as the potencies may not be equivalent
to one another.
F 8. Warfarin is an example of an anticoagulant
T 9. Active bleeding indicates the use of anticoagulants and antiplatelets.
T 10. Patient taking anticoagulants should be advised to avoid activities that could cause traumatic injury or
bleeding.

Activity II. Drug Study

Samantha is a 50-year-old patient. She was tested for lipid profile. Upon checking the results, it was 240mg/dL. The
doctor prescribed her
atorvastatin 10mg tab OD PO. Make a drug study with this drug.
 Drug name Classification Mechanism of Indication Contraindication Adverse Nursing
action reaction Responsibilities

Generic Name Atorvastatin is in a Atorvastatin ● Reduce the ● with ● CNS:

class of competitively risk of non- allergy to ● Headache .
Atorvastatin medications called inhibits 3- fatal ● atorvastati , CLINICAL ALERT!
HMG-CoA hydroxy-3- myocardial n, ● asthenia •
reductase methylglutaryl- infarction. ● fungal ● • Name confusion has
inhibitors coenzyme A ● Reduce the ● byproduct ● GI: been
(statins). It works (HMG-CoA) risk of fatal s, ● Flatulenc reported between
by slowing the reductase. By and non- ● active liver e, written
production of preventing the fatal stroke. ● disease or ● abdomina orders for Lipitor
cholesterol in the conversion of ● Reduce the ● unexplaine l (atorvastatin) and
body to decrease HMG-CoA to risk for d and ● pain, Zyrtec
the amount of mevalonate, statin revasculariz ● persistent cramps, (certirizine). Use
Brand name cholesterol that medications ation ● elevations ● constipati extreme
may build up on the decrease procedures. of on, caution.
Lipitor walls of the arteries cholesterol ● Reduce the ● transamin ● nausea, Assessment
and block blood production in the risk of ase ● dyspepsi •
flow to the heart, liver. hospitalizati ● levels, a, History:
brain, and other on for CHF. ● pregnancy ● heartburn Allergy to
parts of the body. ● Reduce the , , atorvastatin, fungal
risk of ● lactation. ● liver byproducts; active
● • failure hepatic
 angina. ● Use ● • disease; acute
cautiously ● Respirato serious
Actual dosage, ● with ry: illness; pregnancy,
route, frequency impaired ● Sinusitis, lactation
● endocrine ● pharyngit •
● function. is Physical:
Initially, 10 mg ● • Orientation, affect,
PO once daily ● Other: muscle strength;
without regard ● Rhabdom liver
to meals; for yoly evaluation,
maintenance, ● sis with abdominal
10–80 mg PO acute examination; lipid
daily. May be ● renal studies,
combined with failure, LFTs, renal function
bile acid– ● arthralgia tests
binding resin. , Interventions
PEDIATRIC ● myalgia •
PATIENTS 10– ● Obtain LFTs as a
17 baseline
YR and periodically
• during
Initially, 10 mg therapy; discontinue
PO daily. drug if
Maximum, 20 AST or ALT levels
mg/day; do not Source: increase
change dose to 3 times normal
of intervals < 4 levels.
wk. •
WARNING:
Withhold
atorvastatin in any
acute,
serious condition
(severe
infection,
hypotension,
major surgery,
trauma,
severe metabolic or
endocrine disorder,
seizures) that may
suggest
myopathy or serve as
risk
factor for
development of
renal failure.
•
Ensure that patient
has tried